efungumab

As nouns the difference between terms and efungumab

is that terms is while efungumab is a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As nouns the difference between amphotericin and efungumab

is that amphotericin is any of a group of amphoteric antibiotic and antifungal agents derived from Streptomyces bacteria while efungumab is a human monoclonal antibody intended to treat invasive Candida infection in combination with amphotericin B.

As nouns the difference between infection and efungumab

is that infection is (pathology) the act or process of infecting while efungumab is a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As an adjective candida

is .

As a noun efungumab is

a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As nouns the difference between invasive and efungumab

is that invasive is an invasive organism, as, a plant or animal while efungumab is a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As an adjective invasive

is that invades a foreign country using military force.

As an adjective human

is (label) classical (of or pertaining to the classical - latin, greek - languages, literature, history and philosophy).

As a noun efungumab is

a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.